Status:

UNKNOWN

Computerized Cognitive Remediation Therapy in Adolescents With a First Psychotic Episode

Lead Sponsor:

Fundació Sant Joan de Déu

Conditions:

Early-onset Schizophrenia

Psychotic Disorders

Eligibility:

All Genders

12-18 years

Phase:

NA

Brief Summary

Cognitive deficits (CD) are considered one of the essential characteristics in psychotic disorders and occur throughout the course of the disease, being a key characteristic in the evolution of the di...

Detailed Description

Cognitive deficits (DC) are considered one of the essential features in psychotic disorders and occur throughout the course of the disease. Recent meta-analyses have shown that cognitive remediation t...

Eligibility Criteria

Inclusion

  • 1\) Age between 12-18 years
  • 2\) DSM-5 diagnostic criteria for schizophrenia or schizoaffective disorder (F20 or F25, DSM-5) beginning at age 17 or earlier;
  • 3\) Clinically and pharmacologically stabilized;
  • 3\) No changes in drug treatment for 6 weeks from baseline assessment;
  • 4\) Presence of cognitive impairment according to criteria adapted in Penades et al. and following the same criteria in previous studies with similar populations. In this sense, at least one of the following criteria must be present:
  • 2 discrepant scores (a score is discrepant when the T scores are 1 DE below the patient's estimated IQ
  • Either a score T below 37 in persevering Wisconsin Card Sorting Test (WCST) errors by Heaton et al. (1981).
  • 5\) Diagnosis and diagnostic stability verified by a psychiatrist or senior psychologist or member of the research team using the DSM-5 criteria and based on clinical interviews with the patient and his family.

Exclusion

  • 1\) Intellectual disability CI estimated equivalent to or \<70);
  • 2\) Active substance abuse;
  • 3\) Neurological impairment;
  • 4\) Have received electro-convulsive therapy in the 6 months prior to treatment;
  • 5\) Do not sign informed consent.

Key Trial Info

Start Date :

March 19 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2023

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT05405946

Start Date

March 19 2019

End Date

March 1 2023

Last Update

June 27 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital Sant Joan de Deu

Barcelona, Spain, 08950